212 related articles for article (PubMed ID: 6978846)
1. The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice.
Patel M; Havas HF
Immunology; 1982 May; 46(1):97-105. PubMed ID: 6978846
[TBL] [Abstract][Full Text] [Related]
2. Reversal by peritoneal adherent cells of tumor cell suppression of T cell-mediated immunity.
Ting CC; Rodrigues D
J Immunol; 1979 Aug; 123(2):801-7. PubMed ID: 156764
[No Abstract] [Full Text] [Related]
3. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.
Rouse BT; Röllinghoff M; Warner NL
Eur J Immunol; 1973 Apr; 3(4):218-24. PubMed ID: 4541468
[No Abstract] [Full Text] [Related]
4. Immunosuppression in BALB/c mice bearing the plasmacytoma TEPC-183: massive increase in red pulp macrophages induced by the tumour.
Joshua DE; Humphrey JH; Grennan D; Brown G
Immunology; 1980 Jun; 40(2):223-8. PubMed ID: 7409859
[TBL] [Abstract][Full Text] [Related]
5. Effect of splenectomy on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).
Havas HF; Berney S; Goodis A; Schiffman G
Cancer Res; 1979 Sep; 39(9):3783-7. PubMed ID: 476702
[TBL] [Abstract][Full Text] [Related]
6. Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis.
Haubeck HD; Kölsch E
Immunology; 1982 Nov; 47(3):503-10. PubMed ID: 6215340
[TBL] [Abstract][Full Text] [Related]
7. Immunocompetence status as related to growth progression of mouse MOPC-315 plasmacytoma.
Rashid G; Ophir R; Pecht M; Ben-Efraim S
In Vivo; 1989; 3(4):279-84. PubMed ID: 2535271
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of B-lymphocyte clonal proliferation by spleen cells from plasmacytoma-bearing mice.
Hamburger AW
J Natl Cancer Inst; 1980 Dec; 65(6):1337-43. PubMed ID: 6968847
[TBL] [Abstract][Full Text] [Related]
9. Requirement for accessory cells in the antibody response to T cell-independent antigens in vitro.
Lee KC; Shiozawa C; Shaw A; Diener E
Eur J Immunol; 1976 Jan; 6(1):63-8. PubMed ID: 1085699
[TBL] [Abstract][Full Text] [Related]
10. Suppression of the humoral immune response by plasmacytomas: mediation by adherent mononuclear cells.
Kolb JP; Arrian S; Zolla-Pazner S
J Immunol; 1977 Feb; 118(2):702-9. PubMed ID: 138708
[TBL] [Abstract][Full Text] [Related]
11. The effect of an IgM plasmacytoma (TEPC-183) on the primary immune response of BALB/c mice.
Havas HF; Schiffman G
Immunology; 1978 Jan; 34(1):1-8. PubMed ID: 23993
[TBL] [Abstract][Full Text] [Related]
12. Immunosupression of the primary and secondary immune response by an IgM plasmacytoma (TEPC-183).
Havas HF; Schiffman GD; Fenton M; Goodis A; Braverman S
Immunology; 1979 Feb; 36(2):191-7. PubMed ID: 35463
[TBL] [Abstract][Full Text] [Related]
13. Myeloma-induced immunosuppression: a multistep mechanism.
Katzmann JA
J Immunol; 1978 Oct; 121(4):1405-9. PubMed ID: 701801
[TBL] [Abstract][Full Text] [Related]
14. The mode of action of splenic suppressor cells in murine plasmacytoma.
Chen Y; Heller P
Clin Exp Immunol; 1981 Sep; 45(3):514-22. PubMed ID: 6461449
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression in plasmacytoma: induction of suppressor cells.
Chen Y; Hwang LT; Heller P
Clin Exp Immunol; 1982 Jan; 47(1):191-6. PubMed ID: 6212173
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression in a murine B cell leukemia (BCL1): role of an adherent cell in the suppression of primary in vitro antibody responses.
Anderson SA; Isakson PC; Puré E; Muirhead M; Uhr JW; Vitetta ES
J Immunol; 1981 Apr; 126(4):1603-7. PubMed ID: 6451649
[TBL] [Abstract][Full Text] [Related]
17. Cellular specificity of plasmacytoma-induced immunosuppression.
Zolla-Pazner S; Sullivan B; Richardson D
J Immunol; 1976 Aug; 117(2):563-8. PubMed ID: 1084903
[TBL] [Abstract][Full Text] [Related]
18. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
[TBL] [Abstract][Full Text] [Related]
19. Composite activities on B cells of products released by T cells activated by concanavalin A.
Primi D; Lewis GK; Goodman JW
Eur J Immunol; 1979 Aug; 9(8):607-12. PubMed ID: 315320
[No Abstract] [Full Text] [Related]
20. Antibody response of mice following neonatal treatment with a monoclonal anti-receptor antibody. Evidence for B cell tolerance and T suppressor cells specific for different idiotopic determinants.
Cerny J; Cronkhite R; Heusser C
Eur J Immunol; 1983 Mar; 13(3):244-8. PubMed ID: 6187584
[No Abstract] [Full Text] [Related]
[Next] [New Search]
